Holly Hagan
Holly Hagan
Professor Emeritus
-
Professional overview
-
Dr. Holly Hagan is Professor Emeritus at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders. Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.
Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY.
-
Education
-
PhD Epidemiology, University of Washington, Seattle, WAMPH Epidemiology, University of Massachusetts, Amherst, MABA Russian Studies, Evergreen State College, Olympia, WA
-
Publications
Publications
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users
Failed retrieving data.Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users
Failed retrieving data.Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
Failed retrieving data.Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs
Failed retrieving data.Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users : The Study to Reduce Intravenous Exposures (STRIVE)
Failed retrieving data.Distributive syringe sharing among young adult injection drug users in five U.S. cities
Failed retrieving data.Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services
Failed retrieving data.HCV Synthesis Project : Preliminary analyses of HCV prevalence in relation to age and duration of injection
Failed retrieving data.Herpes simplex virus-2 and HIV among noninjecting drug users in New York City
Failed retrieving data.Injecting alone among young adult IDUs in five US cities : Evidence of low rates of injection risk behavior
Failed retrieving data.Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT)
Failed retrieving data.Non-injection drug use and Hepatitis C Virus : A systematic review
Failed retrieving data.Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities
Failed retrieving data.Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities
Failed retrieving data.The transition from injection to non-injection drug use : Long-term outcomes among heroin and cocaine users in New York City
Failed retrieving data.Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among seattle injection drug users aged 18-30 years, 1994-2004
Failed retrieving data.Drug treatment programs' HCV service delivery to their HCV positive clients
Failed retrieving data.Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
Failed retrieving data.Erratum : Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities (Clinical Infectious Diseases (March 1, 2006) 42 (1118-1126))
Failed retrieving data.Hepatitis C knowledge among staff in U.S. drug treatment programs
Failed retrieving data.High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities
Failed retrieving data.HTLV-2 infection in injection drug users in King County, Washington
Failed retrieving data.Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington : Structural and individual-level changes, 1996 versus 2003
Failed retrieving data.Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users
Failed retrieving data.Providing support to drug users infected with hepatitis C : The role of methadone maintenance treatment staff
Failed retrieving data.